Clinical Efficacy of Bladder Neck Injection of Botulinum Toxin A in Treating Neurogenic and Non-Neurogenic Voiding Dysfunctions Due to Bladder Neck Dysfunction
Toxins · 2025
DOI: 10.3390/toxins17060289 ↗Kurz gefasst
Fachartikel in der Zeitschrift Toxins, 2025. Verfasst von Yu-Shuang Lee und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Hualien 970, Taiwan. Hauptthemen laut MEDLINE: Botulinum Toxins, Type A, Urinary Bladder, Neurogenic, Urinary Bladder, Urinary Bladder Neck Obstruction. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Buddhist Tzu Chi Medical Foundation, Tzu Chi Medical Foundation.
Abstract (Originalsprache)
Bladder neck dysfunction (BND) is a pathophysiology associated with voiding dysfunction in patients with neurogenic or non-neurogenic voiding dysfunction. Botulinum toxin A (BoNT-A) injection is a minimally invasive alternative for treating bladder outlet dysfunction; however, its efficacy for BND has not been well established. In this retrospective study, 41 patients with videourodynamic study-confirmed BND who failed medical therapy received a transurethral bladder neck injection of 100-U BoNT-A. Treatment outcomes were assessed using the Global Response Assessment. After BoNT-A injection, the patients were followed up and subsequent urological management was recorded. At 6 months, 65.9% of the patients reported satisfactory outcomes (26.8% successful and 39.0% improved). Patients with non-neurogenic BND had the highest satisfaction rate, higher than those with neurogenic BND (NBND) with and without detrusor sphincter dyssynergia (DSD). Among patients without detrusor acontractility (DA), a higher bladder outlet obstruction index predicted treatment failure. Patients with pure BND confirmed by urodynamics may benefit more from BoNT-A injections, whereas those with high baseline voiding detrusor pressure or spinal cord injury with detrusor sphincter dyssynergia may have less favorable results. Bladder neck BoNT-A injections for treating BND-associated voiding dysfunction did not achieve very successful outcomes. Only 26.8% of the patients had successful treatment outcomes, while 39.0% had improved outcomes and 34.1% failed the treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Urology, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Hualien 970, Taiwan.
- Department of Urology, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Tzu Chi University, Hualien 970, Taiwan.
ORCID-Profile: Yu-Shuang Lee, Yu-Khun Lee, Sheng-Fu Chen, Hann-Chorng Kuo
Förderung
- Buddhist Tzu Chi Medical Foundation
- Tzu Chi Medical Foundation
Zitieren
APA
Lee, Y. S., Lee, Y. K., Chang, T. L., Lee, C. L., Chen, S. F., Jhang, J. F., Jiang, Y. H., & Kuo, H. C. (2025). Clinical Efficacy of Bladder Neck Injection of Botulinum Toxin A in Treating Neurogenic and Non-Neurogenic Voiding Dysfunctions Due to Bladder Neck Dysfunction. Toxins. https://doi.org/10.3390/toxins17060289
Vancouver
Lee YS, Lee YK, Chang TL, Lee CL, Chen SF, Jhang JF, et al. Clinical Efficacy of Bladder Neck Injection of Botulinum Toxin A in Treating Neurogenic and Non-Neurogenic Voiding Dysfunctions Due to Bladder Neck Dysfunction. Toxins. 2025. doi:10.3390/toxins17060289
BibTeX
@article{Lee2025,
author = {Lee, Yu-Shuang and Lee, Yu-Khun and Chang, Tien-Lin and Lee, Cheng-Ling and Chen, Sheng-Fu and Jhang, Jia-Fong and Jiang, Yuan-Hong and Kuo, Hann-Chorng},
title = {Clinical Efficacy of Bladder Neck Injection of Botulinum Toxin A in Treating Neurogenic and Non-Neurogenic Voiding Dysfunctions Due to Bladder Neck Dysfunction},
journal = {Toxins},
year = {2025},
doi = {10.3390/toxins17060289}
}
EUVIMED